|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.32 USD | -2.58% |
|
-6.21% | -47.40% |
| Apr. 15 | RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating | MT |
| Apr. 11 | Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating | MT |
Nevro Corp. increased revenue guidance for the full-year 2023. For the year, the Company now expects full-year 2023 worldwide revenue of approximately $417 million to $419 million, an increase of 3% over prior year on both an as reported and constant currency basis.
This compares to previous guidance of $410 million to $415 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -47.40% | 415M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
NEVRO CORP. 
